217 related articles for article (PubMed ID: 8752297)
1. Protection against rotavirus infections by DNA vaccination.
Herrmann JE; Chen SC; Fynan EF; Santoro JC; Greenberg HB; Wang S; Robinson HL
J Infect Dis; 1996 Sep; 174 Suppl 1():S93-7. PubMed ID: 8752297
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity induced by rotavirus DNA vaccines.
Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE
Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccines against rotavirus infections.
Herrmann JE; Chen SC; Fynan EF; Santoro JC; Greenberg HB; Robinson HL
Arch Virol Suppl; 1996; 12():207-15. PubMed ID: 9015117
[TBL] [Abstract][Full Text] [Related]
4. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
5. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
Gil MT; de Souza CO; Asensi M; Buesa J
Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
[TBL] [Abstract][Full Text] [Related]
6. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Knowlton DR; McNeal MM; Ward RL
Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
[TBL] [Abstract][Full Text] [Related]
7. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.
Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH
Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499
[TBL] [Abstract][Full Text] [Related]
8. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.
Yang K; Wang S; Chang KO; Lu S; Saif LJ; Greenberg HB; Brinker JP; Herrmann JE
Vaccine; 2001 Apr; 19(23-24):3285-91. PubMed ID: 11312027
[TBL] [Abstract][Full Text] [Related]
9. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
[TBL] [Abstract][Full Text] [Related]
10. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model.
Feng N; Vo PT; Chung D; Vo TV; Hoshino Y; Greenberg HB
J Infect Dis; 1997 Feb; 175(2):330-41. PubMed ID: 9203654
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.
Feng N; Burns JW; Bracy L; Greenberg HB
J Virol; 1994 Dec; 68(12):7766-73. PubMed ID: 7966566
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc.
Both GW; Lockett LJ; Janardhana V; Edwards SJ; Bellamy AR; Graham FL; Prevec L; Andrew ME
Virology; 1993 Apr; 193(2):940-50. PubMed ID: 8384761
[TBL] [Abstract][Full Text] [Related]
14. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.
Choi AH; Basu M; McNeal MM; Clements JD; Ward RL
J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847
[TBL] [Abstract][Full Text] [Related]
15. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.
Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA
Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus virus-like particles administered mucosally induce protective immunity.
O'Neal CM; Crawford SE; Estes MK; Conner ME
J Virol; 1997 Nov; 71(11):8707-17. PubMed ID: 9343229
[TBL] [Abstract][Full Text] [Related]
17. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.
Yuan L; Ishida S; Honma S; Patton JT; Hodgins DC; Kapikian AZ; Hoshino Y
J Infect Dis; 2004 May; 189(10):1833-45. PubMed ID: 15122520
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.
Burns JW; Siadat-Pajouh M; Krishnaney AA; Greenberg HB
Science; 1996 Apr; 272(5258):104-7. PubMed ID: 8600516
[TBL] [Abstract][Full Text] [Related]
19. Development of a Bacillus subtilis-based rotavirus vaccine.
Lee S; Belitsky BR; Brinker JP; Kerstein KO; Brown DW; Clements JD; Keusch GT; Tzipori S; Sonenshein AL; Herrmann JE
Clin Vaccine Immunol; 2010 Nov; 17(11):1647-55. PubMed ID: 20810679
[TBL] [Abstract][Full Text] [Related]
20. Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice.
Ishida S; Feng N; Tang B; Gilbert JM; Greenberg HB
J Clin Microbiol; 1996 Jul; 34(7):1694-700. PubMed ID: 8784572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
